Anecortave Acetate (15 Milligrams) versus Photodynamic Therapy for Treatment of Subfoveal Neovascularization in Age-Related Macular Degeneration

Add time:07/22/2019    Source:sciencedirect.com

PurposeTo compare 1-year safety and efficacy of anecortave acetate 15 mg with photodynamic therapy (PDT) with verteporfin in patients eligible for initial PDT treatment.

We also recommend Trading Suppliers and Manufacturers of ANECORTAVE ACETATE RELATED COMPOUND A (20 MG) (9(11 )-DEHYDROCORTISOL) (cas 10184-70-0). Pls Click Website Link as below: cas 10184-70-0 suppliers

Prev:Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration
Next:Anterior Juxtascleral Delivery of Anecortave Acetate in Eyes with Primary Open-Angle Glaucoma: A Pilot Investigation)